CVS GROUP PLC

Transaction in Own Shares • Jan 8, 2026

National Storage Mechanism | Additional information

RNS Number : 0740O

CVS Group plc

08 January 2026

08 January 2026

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 07 January 2026 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	07/01/2026
Aggregate number of Ordinary Shares purchased:	31,334
Lowest price paid per share (GBp):	1,282.00
Highest price paid per share (GBp):	1,334.00
Volume weighted average price paid per share (GBp):	1,292.16

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,612,529 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 70,612,529 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 1,128,254 Ordinary Shares in aggregate at a weighted average price of 1,226.76 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
136	1284	07/01/2026 08:01:13	1366307089943028	XLON
154	1284	07/01/2026 08:01:13	1366307089943029	XLON
35	1282	07/01/2026 08:52:01	1366307089951662	XLON
68	1284	07/01/2026 08:56:13	1366307089952051	XLON
68	1284	07/01/2026 09:45:50	1366307089958307	XLON
32	1284	07/01/2026 09:46:42	1366307089958401	XLON
362	1286	07/01/2026 09:47:15	1366307089958454	XLON
248	1286	07/01/2026 09:47:23	1366307089958461	XLON
68	1288	07/01/2026 09:54:25	1366307089959166	XLON
903	1292	07/01/2026 09:55:47	1366307089959269	XLON
774	1292	07/01/2026 09:55:47	1366307089959276	XLON
800	1288	07/01/2026 09:56:54	1366307089959332	XLON
111	1286	07/01/2026 10:03:59	1366307089959792	XLON
646	1286	07/01/2026 10:03:59	1366307089959793	XLON
309	1286	07/01/2026 10:06:40	1366307089959978	XLON
992	1288	07/01/2026 10:24:22	1366307089961710	XLON
596	1290	07/01/2026 10:29:16	1366307089962332	XLON
68	1290	07/01/2026 10:29:58	1366307089962441	XLON
944	1288	07/01/2026 10:51:11	1366307089964045	XLON
798	1288	07/01/2026 10:57:56	1366307089964398	XLON
188	1288	07/01/2026 10:57:56	1366307089964399	XLON
68	1288	07/01/2026 10:58:04	1366307089964409	XLON
428	1288	07/01/2026 10:59:29	1366307089964510	XLON
68	1290	07/01/2026 11:00:46	1366307089964626	XLON
68	1290	07/01/2026 11:04:18	1366307089964981	XLON
971	1288	07/01/2026 11:06:32	1366307089965114	XLON
959	1288	07/01/2026 11:16:29	1366307089965758	XLON
955	1288	07/01/2026 11:16:29	1366307089965760	XLON
954	1288	07/01/2026 11:23:27	1366307089966124	XLON
793	1288	07/01/2026 11:24:25	1366307089966171	XLON
159	1288	07/01/2026 11:24:25	1366307089966172	XLON
863	1290	07/01/2026 11:27:48	1366307089966506	XLON
454	1288	07/01/2026 11:28:39	1366307089966642	XLON
782	1294	07/01/2026 11:32:33	1366307089966905	XLON
778	1294	07/01/2026 11:32:33	1366307089966907	XLON
769	1292	07/01/2026 11:32:41	1366307089966916	XLON
303	1290	07/01/2026 11:32:49	1366307089966924	XLON
400	1290	07/01/2026 11:33:17	1366307089966960	XLON
600	1292	07/01/2026 11:33:43	1366307089966990	XLON
68	1292	07/01/2026 11:34:02	1366307089967011	XLON
346	1294	07/01/2026 11:37:35	1366307089967394	XLON
183	1294	07/01/2026 11:37:35	1366307089967397	XLON
75	1292	07/01/2026 11:41:54	1366307089967767	XLON
171	1292	07/01/2026 11:41:54	1366307089967769	XLON
147	1290	07/01/2026 12:00:00	1366307089969490	XLON
139	1290	07/01/2026 12:17:52	1366307089970563	XLON
110	1290	07/01/2026 12:17:52	1366307089970567	XLON
208	1290	07/01/2026 12:26:20	1366307089971235	XLON
68	1294	07/01/2026 12:27:25	1366307089971337	XLON
717	1292	07/01/2026 12:48:43	1366307089972621	XLON
160	1294	07/01/2026 12:58:55	1366307089973331	XLON
477	1292	07/01/2026 12:59:16	1366307089973356	XLON
92	1292	07/01/2026 13:03:10	1366307089973788	XLON
701	1292	07/01/2026 13:07:50	1366307089974233	XLON
81	1292	07/01/2026 13:07:56	1366307089974237	XLON
172	1292	07/01/2026 13:07:56	1366307089974238	XLON
70	1292	07/01/2026 13:08:59	1366307089974381	XLON
19	1290	07/01/2026 13:16:03	1366307089975154	XLON
114	1290	07/01/2026 13:16:03	1366307089975155	XLON
736	1292	07/01/2026 13:48:54	1366307089978029	XLON
736	1294	07/01/2026 13:49:22	1366307089978071	XLON
381	1294	07/01/2026 13:49:22	1366307089978072	XLON
741	1292	07/01/2026 13:50:36	1366307089978192	XLON
742	1292	07/01/2026 13:53:01	1366307089978354	XLON
754	1290	07/01/2026 13:54:10	1366307089978490	XLON
773	1294	07/01/2026 14:03:16	1366307089979302	XLON
724	1294	07/01/2026 14:12:20	1366307089980604	XLON
716	1292	07/01/2026 14:12:37	1366307089980635	XLON
765	1302	07/01/2026 14:14:49	1366307089980895	XLON
342	1302	07/01/2026 14:14:49	1366307089980897	XLON
217	1334	07/01/2026 15:18:28	1366307089995469	XLON
917	1330	07/01/2026 15:18:39	1366307089995492	XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                                            [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSUPUPWGUPQGBM